FutureSearch Trials of Dallas | ClinicalTrials HQ

13 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study Evaluating the Efficacy, Safety, and Tolerability of ASY202 (Dihydroergotamine Mesylate [DHE] Inhalation Powder Delivered Via a Multidose Dry Powder Inhaler) for the Acute Treatment of Migraine in Adult Patients	brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, nervous system disorder	Recruiting	Phase 2	2026-10-09		NCT07646613
A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH	Disorders of Excessive Somnolence, Dyssomnias, Sleep Disorders, Intrinsic, idiopathic hypersomnia, narcolepsy, nervous system disorder, psychiatric disorder, sleep-wake disorder	Recruiting	Phase 3	2026-10-08		NCT07625280
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 2	2026-10-08		NCT07589608
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight	Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition	Recruiting	Phase 2	2026-10-07		NCT06143956
Study of EVO756 in Adults With Migraine	brain disorder, central nervous system disorder, headache disorder, hypnic headache, migraine disorder, migraine with aura, migraine without aura, nervous system disorder	Recruiting	Phase 2	2026-10-02		NCT07616128
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine	Preventive Treatment of Migraine	Recruiting	Phase 3	2026-09-25		NCT07729462
A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)	depressive disorder, major depressive disorder, mood disorder, psychiatric disorder	Recruiting	Phase 2	2026-09-25		NCT07621237
A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine	Acute Treatment of Migraine	Recruiting	Phase 4	2026-09-25		NCT07609914
A Trial of the Efficacy and Safety of Fixed Doses of SEP-363856 in Adults With Generalized Anxiety Disorder	anxiety disorder, generalized anxiety disorder, psychiatric disorder	Recruiting	Phase 3	2026-09-22		NCT07759128
DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.	Apnea, Dyssomnias, Respiration Disorders, Sleep Disorders, Intrinsic, nervous system disorder, obstructive sleep apnea syndrome, respiratory system disorder, sleep apnea syndrome, sleep-wake disorder	Recruiting	Phase 2	2026-09-22		NCT07635563
A Study of Brenipatide in Adults Who Quit Smoking Cigarettes and Want to Avoid Relapse	Smoking	Recruiting	Phase 2	2026-09-22		NCT07223840
A Study to Investigate the Treatment Effect of Subcutaneous Injections of Pentosan Polysulfate Sodium Compared With Placebo in Adult Participants With Knee Osteoarthritis Pain.	arthritic joint disease, arthropathy, musculoskeletal system disorder, osteoarthritis, osteoarthritis, knee, rheumatic disorder	Active, not recruiting	Phase 3	2026-09-01		NCT06917404
A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine	Menstrual Migraine	Recruiting	Phase 3	2026-07-09		NCT06641466